As of 2025-05-09, the EV/EBITDA ratio of Kalbe Farma Tbk PT (KLBF.JK) is 14.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KLBF.JK's latest enterprise value is 63,338,430.00 mil IDR. KLBF.JK's TTM EBITDA according to its financial statements is 4,450,699.50 mil IDR. Dividing these 2 quantities gives us the above KLBF.JK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.0x - 10.5x | 9.8x |
| Forward P/E multiples | 6.2x - 7.7x | 7.0x |
| Fair Price | 846.47 - 1,083.84 | 997.98 |
| Upside | -41.2% - -24.7% | -30.7% |
| Date | EV/EBITDA |
| 2025-05-07 | 13.86 |
| 2025-05-06 | 13.92 |
| 2025-05-05 | 13.70 |
| 2025-05-02 | 12.91 |
| 2025-04-30 | 13.44 |
| 2025-04-29 | 12.34 |
| 2025-04-28 | 12.34 |
| 2025-04-25 | 12.12 |
| 2025-04-24 | 12.39 |
| 2025-04-23 | 12.55 |
| 2025-04-22 | 11.70 |
| 2025-04-21 | 11.97 |
| 2025-04-17 | 11.70 |
| 2025-04-16 | 12.28 |
| 2025-04-15 | 11.65 |
| 2025-04-14 | 12.12 |
| 2025-04-11 | 11.49 |
| 2025-04-10 | 11.12 |
| 2025-04-09 | 10.70 |
| 2025-04-08 | 10.18 |
| 2025-03-27 | 11.02 |
| 2025-03-26 | 10.65 |
| 2025-03-25 | 11.02 |
| 2025-03-24 | 10.70 |
| 2025-03-21 | 10.86 |
| 2025-03-20 | 10.54 |
| 2025-03-19 | 9.91 |
| 2025-03-18 | 9.75 |
| 2025-03-17 | 10.23 |
| 2025-03-14 | 10.12 |
| 2025-03-13 | 10.49 |
| 2025-03-12 | 10.33 |
| 2025-03-11 | 10.23 |
| 2025-03-10 | 10.44 |
| 2025-03-07 | 11.28 |
| 2025-03-06 | 11.18 |
| 2025-03-05 | 10.54 |
| 2025-03-04 | 10.76 |
| 2025-03-03 | 10.76 |
| 2025-02-28 | 10.44 |
| 2025-02-27 | 11.07 |
| 2025-02-26 | 11.55 |
| 2025-02-25 | 11.28 |
| 2025-02-24 | 11.81 |
| 2025-02-21 | 11.91 |
| 2025-02-20 | 11.81 |
| 2025-02-19 | 12.07 |
| 2025-02-18 | 12.70 |
| 2025-02-17 | 12.60 |
| 2025-02-14 | 12.65 |